We recently published These 10 Stocks Fell Hard. Are You Holding Any? Patterson-UTI Energy, Inc. (NASDAQ:PTEN) is one of this ...

Patterson-UTI Energy, Inc. PTEN reported a second-quarter 2025 adjusted net loss of 6 cents per share, which was wider than ...

On Thursday, Patterson-UTI Energy Inc. (NASDAQ:PTEN), a provider of drilling and completion services, reported a larger-than-anticipated loss for the second quarter, impacted by a non-cash asset ...

The share price of Patterson-UTI Energy, Inc. (NASDAQ:PTEN) fell by 9.31% between July 11 and July 18, 2025, putting it among ...

CEO William Andrew Hendricks stated that “the second quarter saw several macro events take place that raised the volatility in the oil markets.” He highlighted that oil prices fluctuated between the ...

Analysts are estimating that Patterson-UTI Energy will report an earnings per share (EPS) of $-0.03. Anticipation surrounds ...

PTEN acts as a tumor suppressor in a range of tissue types and has been implicated in the regulation of intestinal stem cells. To study Pten function in the intestine, ...

Patterson-UTI Energy Inc. (PTEN) on Wednesday reported a loss of $49.1 million in its second quarter. The Houston-based company said it had a loss of 13 cents per share.

Another EGFR pathway is PTEN/PI3K/AKT ().PTEN (phosphatase and tensin homologue gene) encodes a phosphatase, which has as major substrate phosphatidylinositol-3,4,5-triphosphate (PIP-3), which is ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Patterson-UTI Energy Inc. (Symbol: PTEN), where a total of 51,930 contracts have traded ...

PTEN-PI3K-AKT pathway CNVs were readily detected using our cfDNA assay, with the prevalence of PTEN loss comparable with tissue-based studies. Additional PTEN-PI3K-AKT pathway aberrations were found ...